In 9971 adults aged ≥70 without cardiovascular disease, diabetes or dementia, atorvastatin 40 mg cut major cardiovascular events vs placebo over 5.9 years (10.9 vs 15.5/1000 person-years; HR 0.70) but did not improve disability-free survival (HR 0.94; P=0.25).
RCTn = 9,971
Zoungas et al. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults